Local view for "http://purl.org/linkedpolitics/eu/plenary/2003-12-17-Speech-3-104"
Predicate | Value (sorted: default) |
---|---|
rdf:type | |
dcterms:Date | |
dcterms:Is Part Of | |
dcterms:Language | |
lpv:document identification number |
"en.20031217.4.3-104"2
|
lpv:hasSubsequent | |
lpv:speaker | |
lpv:spokenAs | |
lpv:translated text |
".
The agreement that has just been reached in Parliament was based on a misguided Commission proposal, which viewed the matter in exclusively commercial terms and which sought to review the process of legislating on medicines, with the basic aim of increasing the short-tern competitiveness of the pharmaceutical industry.
This position was immediately contested by various social, consumer, family and mutual organisations from various countries, all fighting for a responsible policy that will serve public health and consumer protection. Consequently, at first reading, Parliament was able to make substantial changes to the Commission proposals, which the Council only accepted in part.
At second reading, some of the original proposals were accepted and whilst the compromise that has been voted on today in the European Parliament does not accept all the proposals that we put forward, it significantly improves the Council position, specifically as regards defining generic medicines, as regards the request for a distinction to be made between advertising and information and as regards the invitation to the Commission to undertake a study of current practices in the field of information, with the aim of improving quality."@en1
|
Named graphs describing this resource:
The resource appears as object in 2 triples